Market News

Deal Solidifies Curaleaf's Strategic Advantage in Germany as the Country Prepares for Adult-Use

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced the completion of its agreement to acquire a 55% stake in Four 20 Pharma GmbH, a fully EU-GMP & GDP licensed German producer and distributor of medical cannabis.

Boris Jordan , Executive Chairman of Curaleaf, stated, "We are pleased to complete the transaction with Four 20 Pharma and I am personally thrilled to welcome Torsten and Thomas to the Curaleaf family. Our early focus on Europe has given Curaleaf a formidable strategic asset and strong foundation in one of the industry's critical global markets. Curaleaf is the only U.S. MSO uniquely positioned to capitalize on the opportunity."

With the close of the transaction, Curaleaf has solidified a strategic pathway to acquire complete control of Four 20 Pharma after two years of the commencement of adult-use in Germany , which is slated to begin in early 2024.

Miles Worne , President of Curaleaf International, said, "Four 20 Pharma is an ideal asset to accelerate our growth in Germany as the country readies for its conversion from medical cannabis to adult-use. Curaleaf International continues to build our platform in eight markets, and this deal further underscores our aspiration to be a major player in the European market and the global industry leader."

About Curaleaf Holdings

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States , Curaleaf currently operates in 21 states with 137 dispensaries, 26 cultivation sites, and employs over 6,000 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com .

About Four20 Pharma

Four 20 Pharma is a leading, fully EU-GMP & GDP licensed European producer and distributor of medical cannabis with industry-leading product quality and best-in-class regulatory expertise. Four 20 Pharma entered the German market with the vision to guarantee continuous patient care, and since the launch in 2020 of its "420NATURAL" brand, the company has created a steady supply chain to deliver the best possible cannabis products to its patients. The company employs 41 team members and is based in Paderborn, Germany.

FORWARD-LOOKING STATEMENTS

This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or, "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward–looking statements and information concerning the opening of a new dispensary in Allentown, Pennsylvania . Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed March 9, 2022 , which is available under the Company's SEDAR profile at http://www.sedar.com , and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

INVESTOR CONTACT
Curaleaf Holdings, Inc.
Camilo Lyon , Chief Investment Officer
IR@curaleaf.com

MEDIA CONTACTS
Curaleaf Holdings, Inc.
Tracy Brady , SVP Corporate Communications
media@curaleaf.com

Four20 Pharma GmbH
Christopher Thiele
christopher.thiele@420pharma.eu

Cision View original content: https://www.prnewswire.com/news-releases/curaleaf-completes-majority-stake-acquisition-of-germanys-four-20-pharma-301626838.html

SOURCE Curaleaf Holdings, Inc.

News Provided by PR Newswire via QuoteMedia

CURA:CNX,CURLF

Green Thumb Industries to Hold Third Quarter 2022 Earnings Conference Call on November 2, 2022

Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries today announced it will release third quarter financial results after the market closes on Wednesday, November 2, 2022.

A conference call and audio webcast will also be held on Wednesday, November 2, 2022, at 5:00 p.m. Eastern Time/4:00 p.m. Central Time to discuss the results and answer any questions.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Canopy Growth Announces Divestiture of Canadian Retail Operations

Decision supports the Company's strategic objectives including streamlining Canadian operations, achieving profitability, and advancing a premium brand-driven portfolio for consumers

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) announced today that the Company has entered into agreements to divest its retail business across Canada which includes the stores operating under the Tweed and Tokyo Smoke retail banners. The announcement reinforces the Company's focus on advancing its path to profitability as a premium brand-focused cannabis and consumer packaged goods (CPG) company.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

TerrAscend and TRP Announce Partnership To Bring Global Cannabis Brand Cookies Into Pennsylvania Market

TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER) (OTCQX: TRSSF), a North American cannabis operator, today announced that it has entered into an agreement with TRP - the cannabis holding and operating company with the exclusive rights to introduce the nation's most coveted Cookies products to Pennsylvania . Strains from Cookies premium genetics will be made available at TerrAscend dispensaries across the Commonwealth and Cookies stores owned and operated by TRP to open in the coming months. Under the terms of the multi-year agreement, TerrAscend will cultivate and manufacture Cookies products in the Keystone State.

In the coming weeks, TerrAscend will launch Cookies products at each of the Company's 'Apothecarium' and 'Keystone Canna Remedies' dispensary retail chains across Pennsylvania .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Launches Khalifa Kush Cannabis in Florida Through Exclusive Partnership with Wiz Khalifa

GRAMMY® and Golden Globe® Award-nominated artist Wiz Khalifa to meet patients in three Trulieve dispensaries October 1

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the official launch of Khalifa Kush premium medical cannabis products in select Florida retail locations this Saturday, October 1 . This is an exclusive partnership with multi-platinum selling, GRAMMY® and Golden Globe® Award-nominated recording artist Wiz Khalifa in Florida . Patients can visit any Trulieve location in Florida on October 1 for a chance to receive Khalifa Kush swag and prizes.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Opens New Medical Cannabis Dispensary in Milton, West Virginia

Grand opening celebration event on Sept. 24

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the grand opening of its newest West Virginia dispensary in Milton at 5 Perry Morris Square. The Milton dispensary will open its doors on Sept. 24 at 10 a.m. EDT for patients, with ongoing hours of 10 a.m. to 8 p.m. from Monday through Saturday, and 10 a.m. to 6 p.m. on Sunday .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Opens New Medical Cannabis Dispensary in Belle, West Virginia

Grand opening celebration event on Sept. 24

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the grand opening of its newest West Virginia dispensary in Belle at 2700 Dupont Ave Suite 9. The Belle dispensary will open its doors on Sept. 24 at 10 a.m. EDT for patients, with ongoing hours of 10 a.m. to 8 p.m. from Monday through Saturday, and 10 a.m. to 6 p.m. on Sunday .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×